I

Innocan Pharma Corp
CNSX:INNO

Watchlist Manager
Innocan Pharma Corp
CNSX:INNO
Watchlist
Price: 6.5 CAD -1.22% Market Closed
Market Cap: CA$29.3m

Innocan Pharma Corp
Other Items

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Innocan Pharma Corp
Other Items Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Items CAGR 3Y CAGR 5Y CAGR 10Y
I
Innocan Pharma Corp
CNSX:INNO
Other Items
$1k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Teva Pharmaceutical Industries Ltd
TASE:TEVA
Other Items
$1.2B
CAGR 3-Years
1%
CAGR 5-Years
-3%
CAGR 10-Years
N/A
Mediwound Ltd
NASDAQ:MDWD
Other Items
-$12.4m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
P
Purple Biotech Ltd
TASE:PPBT
Other Items
$774k
CAGR 3-Years
-65%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Scisparc Ltd
NASDAQ:SPRC
Other Items
-$1.6m
CAGR 3-Years
-244%
CAGR 5-Years
N/A
CAGR 10-Years
-32%
T
Tikun Olam Cannbit Pharmaceuticals Ltd
TASE:TKUN
Other Items
₪448k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Innocan Pharma Corp
Glance View

Market Cap
29.3m CAD
Industry
N/A

InnoCan Pharma Corp. focuses on the development and sale of CBD-integrated pharmaceuticals including topical treatments for relief of psoriasis symptoms as well as the treatment of muscle pain and rheumatic pain. The company operates through three distinct operating segments: Research, Development, Marketing, Distribution and sales of InnoCan-branded over the counter (OTC) pharmaceutical products; Research and Development of Non-pharmaceutical products for third parties and Research and Development of hydrogels containing liposomes intended for licensing or sale to third party pharmaceutical corporations for manufacturing, distribution and sales. The firm is developing an OTC topical treatments product line and new platform to facilitate the targeted controlled administration of cannabinoids via injection.

INNO Intrinsic Value
16.75 CAD
Undervaluation 61%
Intrinsic Value
Price CA$6.5
I

See Also

What is Innocan Pharma Corp's Other Items?
Other Items
1k USD

Based on the financial report for Dec 31, 2025, Innocan Pharma Corp's Other Items amounts to 1k USD.

What is Innocan Pharma Corp's Other Items growth rate?
Other Items CAGR 1Y
-99%

Over the last year, the Other Items growth was -99%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett